Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a -14.977% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a Brc1ccccc1-c1nc2c3ccccc3ncn2n1
b CNS(=O)(=O)c1cc(C(=O)OCC(=O)NC2CCCc3ccccc32)ccc1Cl
c Cc1ccc(C(=O)N/C(=C/c2ccco2)C(=O)N2CCOCC2)cc1
d Br.CCCCCCCCn1c2c(c(=N)c3c1CCC3)CCCC2
Answer: a. Brc1ccccc1-c1nc2c3ccccc3ncn2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Brc1ccccc1-c1nc2c3ccccc3ncn2n1
Brc1ccccc1-c1nc2c3ccccc3ncn2n1
4-(2-bromophenyl)-3,5,6,8-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2,4,7,9,11-hexaene